Cooley: #1 in Life Sciences Venture Capital Financing

Palo Alto – February 2, 2016 – For the third year in a row, Cooley has been ranked the most active law firm in 2015 for life sciences venture financings according to data from VentureSource, Dow Jones's comprehensive global database on companies backed by venture capital and private equity.

"Cooley plays a pivotal role in the growth of many of the world's most promising life sciences companies," said Barbara Kosacz, partner and head of the firm's global life sciences group. "The depth and breadth of our industry knowledge allows us to add unique value for our clients across this dynamic sector."

The firm's international client base includes both public and private companies and spans a breadth of the life sciences sectors from therapeutics to drug delivery and formulation to medical technology.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.